Cargando…

A budget impact analysis of substituting sitagliptin with liraglutide in type 2 diabetes from a private health insurance perspective in Egypt

INTRODUCTION: Type 2 diabetes mellitus causes a sizable burden globally from both health and economic points of view. This study aimed to assess the budget impact of substituting sitagliptin with liraglutide versus other glucose-lowering drugs from the private health insurance perspective in Egypt o...

Descripción completa

Detalles Bibliográficos
Autores principales:	Elsisi, Gihan Hamdy, Afify, Ayman, Abgad, Ashraf, Zakaria, Ibtissam, Nasif, Nabil, Ibrahim, Hani Naiem, Raafat, Nabil, Carapinha, João L.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2022
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8760653/ https://www.ncbi.nlm.nih.gov/pubmed/35033094 http://dx.doi.org/10.1186/s12962-021-00335-y

Ejemplares similares

The budget impact of alteplase in the treatment of acute ischemic stroke in Egypt
por: Aref, Hany, et al.
Publicado: (2023)

Projecting the Potential Budget Impact Analysis of Paliperidone Palmitate in Egyptian Adult Patients with Schizophrenia
por: Elsisi, Gihan, et al.
Publicado: (2023)

The effect of liraglutide and sitagliptin on oxidative stress in persons with type 2 diabetes
por: Sivalingam, Suvanjaa, et al.
Publicado: (2021)

Cost–benefit comparison of liraglutide and sitagliptin in the treatment of type 2 diabetes in Thailand
por: Deerochanawong, Chaicharn, et al.
Publicado: (2019)

Estimation of Prostate Cancer Cost in Egypt From a Societal Perspective
por: Elsisi, Gihan Hamdy, et al.
Publicado: (2023)

Comparative Effectiveness of Empagliflozin vs Liraglutide or Sitagliptin in Older Adults With Diverse Patient Characteristics
por: Htoo, Phyo T., et al.
Publicado: (2022)

The Budget and Private Enclosed Gardens
por: Lawrence-Hamilton, J.
Publicado: (1909)

Incretin Therapy for Type 2 Diabetes in Spain: A Cost-Effectiveness Analysis of Liraglutide Versus Sitagliptin
por: Mezquita Raya, Pedro, et al.
Publicado: (2013)

The Effectiveness of Liraglutide in Nonalcoholic Fatty Liver Disease Patients with Type 2 Diabetes Mellitus Compared to Sitagliptin and Pioglitazone
por: Ohki, Takamasa, et al.
Publicado: (2012)

p53, Bcl-2 and C-Myc Expressions in Colorectal Carcinoma Associated with Schistosomiasis in Egypt
por: Zalata, Khaled R., et al.
Publicado: (2005)

Cost–utility analysis of liraglutide compared with sulphonylurea or sitagliptin, all as add-on to metformin monotherapy in Type 2 diabetes mellitus
por: Davies, M J, et al.
Publicado: (2012)

Divergent Effects of Liraglutide, Exendin-4, and Sitagliptin on Beta-Cell Mass and Indicators of Pancreatitis in a Mouse Model of Hyperglycaemia
por: Mondragon, Angeles, et al.
Publicado: (2014)

Real-World Clinical and Economic Outcomes of Liraglutide Versus Sitagliptin in Patients with Type 2 Diabetes Mellitus in the United States
por: Li, Qian, et al.
Publicado: (2014)

Cost-Effectiveness Analysis of Incretin Therapy for Type 2 Diabetes in Spain: 1.8 mg Liraglutide Versus Sitagliptin
por: Pérez, Antonio, et al.
Publicado: (2015)

Biliary effects of liraglutide and sitagliptin, a 12‐week randomized placebo‐controlled trial in type 2 diabetes patients
por: Smits, Mark M., et al.
Publicado: (2016)

Epidemiology and clinical presentation of stroke in Upper Egypt (desert area)
por: El Tallawy, Hamdy N, et al.
Publicado: (2015)

Real-World Clinical Effectiveness and Cost Savings of Liraglutide Versus Sitagliptin in Treating Type 2 Diabetes for 1 and 2 Years
por: Li, Qian, et al.
Publicado: (2018)

Twelve week liraglutide or sitagliptin does not affect hepatic fat in type 2 diabetes: a randomised placebo-controlled trial
por: Smits, Mark M., et al.
Publicado: (2016)

Molecular docking studies of HIV TAT and sitagliptin nano-formula as potential therapeutic targeting SARS-CoV2 protease
por: Asfour, Hani Z., et al.
Publicado: (2021)

Neurologists’ Knowledge, Practice, and Attitudes towards Pharmacovigilance and Adverse Drug Reactions Reporting Process in Epileptic Patients—Comparative Analysis from Poland and Egypt
por: Kopciuch, Dorota, et al.
Publicado: (2022)

Cost-effectiveness analysis of liraglutide versus sitagliptin or exenatide in patients with inadequately controlled Type 2 diabetes on oral antidiabetic drugs in Greece
por: Tzanetakos, Charalampos, et al.
Publicado: (2014)

Efficacy and safety of liraglutide versus sitagliptin both in combination with metformin in patients with type 2 diabetes: A systematic review and meta-analysis
por: Li, Mingxing, et al.
Publicado: (2017)

Clinical Effectiveness of Liraglutide vs Sitagliptin on Glycemic Control and Body Weight in Patients with Type 2 Diabetes: A Retrospective Assessment in Sweden
por: Lind, Marcus, et al.
Publicado: (2016)

Oral Semaglutide Versus Empagliflozin, Sitagliptin and Liraglutide in the UK: Long-Term Cost-Effectiveness Analyses Based on the PIONEER Clinical Trial Programme
por: Bain, Stephen C., et al.
Publicado: (2019)

Evaluating the Short-Term Cost-Effectiveness of Liraglutide Versus Sitagliptin in Patients with Type 2 Diabetes Failing Metformin Monotherapy in the United States
por: Langer, Jakob, et al.
Publicado: (2013)

Impact of COVID-19 pandemic on the neurosurgical practice in Egypt
por: Nabil, Mohamed, et al.
Publicado: (2022)

Prevalence of Parkinson’s disease and other types of Parkinsonism in Al Kharga district, Egypt
por: EL-Tallawy, Hamdy N, et al.
Publicado: (2013)

Population-based study of acquired cerebellar ataxia in Al-Kharga district, New Valley, Egypt
por: Farghaly, Wafaa MA, et al.
Publicado: (2011)

Epidemiology of non-fatal cerebrovascular stroke and transient ischemic attacks in Al Quseir, Egypt
por: El-Tallawy, Hamdy N, et al.
Publicado: (2013)

Door-to-door survey of major neurological disorders (project) in Al Quseir City, Red Sea Governorate, Egypt
por: Tallawy, Hamdy NA El, et al.
Publicado: (2013)

Sitagliptin, sitagliptin and metformin, or sitagliptin and amitriptyline attenuate streptozotocin-nicotinamide induced diabetic neuropathy in rats
por: Sharma, Ashish Kumar, et al.
Publicado: (2012)

Prevalence of multiple sclerosis in Al Quseir city, Red Sea Governorate, Egypt
por: El-Tallawy, Hamdy N, et al.
Publicado: (2016)

The Burden of Obesity in Egypt
por: Aboulghate, Mohamed, et al.
Publicado: (2021)

Budget Impact of Oral Semaglutide Intensification versus Sitagliptin among US Patients with Type 2 Diabetes Mellitus Uncontrolled with Metformin
por: Wehler, Elizabeth, et al.
Publicado: (2020)

Repurposing of Sitagliptin- Melittin Optimized Nanoformula against SARS-CoV-2; Antiviral Screening and Molecular Docking Studies
por: Al-Rabia, Mohammed W., et al.
Publicado: (2021)

Factors Affecting Survival of Women Diagnosed with Breast Cancer in El-Minia Governorate, Egypt
por: Seedhom, Amany Edward, et al.
Publicado: (2011)

The Palliative Performance Scale Predicts Survival among Emergency Department Patients, Minia, Egypt
por: Seedhom, Amany Edward, et al.
Publicado: (2017)

Microbiological testing of pharmaceuticals and cosmetics in Egypt
por: Zeitoun, Hend, et al.
Publicado: (2015)

Upper Egypt experience in bladder preservation using concurrent chemoradiotherapy
por: Maklad, Ahmed M, et al.
Publicado: (2013)

Ophthalmoplegia in a Her2+ and β-hCG+ Patient With Leptomeningeal Carcinomatosis Secondary to Gastric Adenocarcinoma
por: Falk, Zachary, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_63gvkhgfg39r55jtrtjpe8a1q9